These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 7844536

  • 1. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
    Schlesinger JJ, Chapman S.
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():217-20. PubMed ID: 7844536
    [Abstract] [Full Text] [Related]

  • 2. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.
    Schlesinger JJ, Foltzer M, Chapman S.
    Virology; 1993 Jan; 192(1):132-41. PubMed ID: 8517015
    [Abstract] [Full Text] [Related]

  • 3. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
    Brandriss MW, Schlesinger JJ, Walsh EE, Briselli M.
    J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay.
    Adungo F, Yu F, Kamau D, Inoue S, Hayasaka D, Posadas-Herrera G, Sang R, Mwau M, Morita K.
    Clin Vaccine Immunol; 2016 Aug; 23(8):689-97. PubMed ID: 27307452
    [Abstract] [Full Text] [Related]

  • 9. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
    Brezski RJ, Kinder M, Grugan KD, Soring KL, Carton J, Greenplate AR, Petley T, Capaldi D, Brosnan K, Emmell E, Watson S, Jordan RE.
    MAbs; 2014 Aug; 6(5):1265-73. PubMed ID: 25517311
    [Abstract] [Full Text] [Related]

  • 10. Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools.
    Gould EA, Buckley A, Cane PA, Higgs S, Cammack N.
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1889-94. PubMed ID: 2472467
    [Abstract] [Full Text] [Related]

  • 11. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.
    Gould EA, Buckley A, Cammack N, Barrett AD, Clegg JC, Ishak R, Varma MG.
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1369-82. PubMed ID: 2410549
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Analysis of 17D yellow fever virus envelope protein epitopes using monoclonal antibodies.
    Schlesinger JJ, Walsh EE, Brandriss MW.
    J Gen Virol; 1984 Oct; 65 ( Pt 10)():1637-44. PubMed ID: 6208313
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 17D yellow fever virus infection of P388D1 cells mediated by monoclonal antibodies: properties of the macrophage Fc receptor.
    Schlesinger JJ, Brandriss MW.
    J Gen Virol; 1983 Jun; 64 (Pt 6)():1255-62. PubMed ID: 6854270
    [Abstract] [Full Text] [Related]

  • 17. Attenuation of wild-type yellow fever virus by passage in HeLa cells.
    Barrett AD, Monath TP, Cropp CB, Adkins JA, Ledger TN, Gould EA, Schlesinger JJ, Kinney RM, Trent DW.
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2301-6. PubMed ID: 2230735
    [Abstract] [Full Text] [Related]

  • 18. Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus.
    Barrett AD, Mathews JH, Miller BR, Medlen AR, Ledger TN, Roehrig JT.
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():13-8. PubMed ID: 1689367
    [Abstract] [Full Text] [Related]

  • 19. Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes.
    Ryman KD, Ledger TN, Weir RC, Schlesinger JJ, Barrett AD.
    J Gen Virol; 1997 Jun; 78 ( Pt 6)():1353-6. PubMed ID: 9191929
    [Abstract] [Full Text] [Related]

  • 20. Japanese encephalitis virus/yellow fever virus chimera is safe and confers full protection against yellow fever virus in intracerebrally challenged mice.
    Yang H, Yang H, Li Z, Liu L, Wang W, He T, Fan F, Sun Y, Liu J, Li Y, Zeng X.
    Vaccine; 2018 Apr 25; 36(18):2450-2455. PubMed ID: 29580643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.